Metabolomics Analysis Reveals Molecular Signatures of Metabolic Complexity in Children with Hypercholesterolemia

Despite the importance of hypercholesterolemia in children, it is overlooked, and there are currently few metabolomics-based approaches available to understand its molecular mechanisms. Children from a birth cohort had their cholesterol levels measured with the aim of identifying the metabolites for the molecular biological pathways of childhood hypercholesterolemia. One hundred and twenty-five children were enrolled and stratified into three groups according to cholesterol levels (acceptable, <170 mg/dL, n = 42; borderline, 170–200 mg/dL, n = 52; and high, >200 mg/dL, n = 31). Plasma metabolomic profiles were obtained by using 1H-nuclear magnetic resonance (NMR) spectroscopy, and partial least squares-discriminant analysis (PLS-DA) was applied using the MetaboAnalyst 5.0 platform. Metabolites significantly associated with different cholesterol statuses were identified, and random forest classifier models were used to rank the importance of these metabolites. Their associations with serum lipid profile and functional metabolic pathways related to hypercholesterolemia were also assessed. Cholesterol level was significantly positively correlated with LDL-C and Apo-B level, as well as HDL-C and Apo-A1 level separately, whereas HDL-C was negatively correlated with triglyceride level (p < 0.01). Eight metabolites including tyrosine, glutamic acid, ornithine, lysine, alanine, creatinine, oxoglutaric acid, and creatine were significantly associated with the different statuses of cholesterol level. Among them, glutamic acid and tyrosine had the highest importance for different cholesterol statuses using random forest regression models. Carbohydrate and amino acid metabolisms were significantly associated with different cholesterol statuses, with glutamic acid being involved in all amino acid metabolic pathways (FDR-adjusted p < 0.01). Hypercholesterolemia is a significant health concern among children, with up to 25% having high cholesterol levels. Glutamic acid and tyrosine are crucial amino acids in lipid metabolism, with glutamic-acid-related amino acid metabolism playing a significant role in regulating cholesterol levels.

[1]  P. Song,et al.  Dietary Branched-Chain Amino Acids (BCAAs) and Risk of Dyslipidemia in a Chinese Population , 2022, Nutrients.

[2]  T. Lehtimäki,et al.  Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events. , 2022, The New England journal of medicine.

[3]  L. Kasselman,et al.  Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target , 2021, Metabolites.

[4]  H. Peckham,et al.  Sex hormones drive changes in lipoprotein metabolism , 2021, iScience.

[5]  M. Sanz,et al.  Primary hypercholesterolemia and development of cardiovascular disorders: cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction. , 2021, The international journal of biochemistry & cell biology.

[6]  Yue-xin Yang,et al.  Serum Metabolomics Reveals Underlying Mechanisms of Cholesterol-Lowering Effects of Oat Consumption: A Randomized Controlled Trial in a Mildly Hypercholesterolemic Population. , 2021, Molecular nutrition & food research.

[7]  Xiao-Fan Wang,et al.  Targeted profiling of amino acid metabolome in serum by a liquid chromatography-mass spectrometry method: application to identify potential markers for diet-induced hyperlipidemia. , 2020, Analytical methods : advancing methods and applications.

[8]  A. Schienkiewitz,et al.  Age, maturation and serum lipid parameters: findings from the German Health Survey for Children and Adolescents , 2019, BMC Public Health.

[9]  A. Zhang,et al.  Metabolomics biotechnology, applications, and future trends: a systematic review , 2019, RSC advances.

[10]  B. Kingwell,et al.  Rethinking good cholesterol: a clinicians' guide to understanding HDL. , 2019, The lancet. Diabetes & endocrinology.

[11]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[12]  S. Grundy,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[13]  J. Steinberger,et al.  Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[14]  J. Adamski,et al.  Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations , 2018, Nutrition & Metabolism.

[15]  Ghada A. Soliman Dietary Cholesterol and the Lack of Evidence in Cardiovascular Disease , 2018, Nutrients.

[16]  Fan Li,et al.  Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes , 2018, Current medical research and opinion.

[17]  T. Henriksen,et al.  Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study. , 2017, Atherosclerosis.

[18]  Po-Yin Chang,et al.  Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study , 2017, Diabetes Care.

[19]  C. Deborde,et al.  NMRProcFlow: a graphical and interactive tool dedicated to 1D spectra processing for NMR-based metabolomics , 2016, Metabolomics.

[20]  P. Lozano,et al.  Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.

[21]  M. Cheng,et al.  Metabolomic Profiling of Infectious Parapneumonic Effusions Reveals Biomarkers for Guiding Management of Children with Streptococcus pneumoniae Pneumonia , 2016, Scientific Reports.

[22]  A. Rodday,et al.  Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES) , 2016, Circulation.

[23]  T. Reinehr,et al.  Tyrosine Is Associated with Insulin Resistance in Longitudinal Metabolomic Profiling of Obese Children , 2015, Journal of diabetes research.

[24]  A. Marette,et al.  Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk. , 2015, American journal of physiology. Endocrinology and metabolism.

[25]  Á. Gil-Izquierdo,et al.  Metabolomics and the diagnosis of human diseases--a guide to the markers and pathophysiological pathways affected. , 2014, Current medicinal chemistry.

[26]  N. Chu,et al.  Prevalence and trend of dyslipidaemia from 1996 to 2006 among normal and overweight adolescents in Taiwan , 2014, BMJ Open.

[27]  M. Akram Citric Acid Cycle and Role of its Intermediates in Metabolism , 2014, Cell Biochemistry and Biophysics.

[28]  L. Aronne,et al.  Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. , 2013, Journal of clinical lipidology.

[29]  Y. Ishizaka,et al.  Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects , 2012, Clinical obesity.

[30]  D. Labarthe,et al.  Project HeartBeat! Concept, development, and design. , 2009, American journal of preventive medicine.

[31]  S. Daniels,et al.  Lipid Screening and Cardiovascular Health in Childhood , 2008, Pediatrics.

[32]  J. Strong,et al.  Origin of atherosclerosis in childhood and adolescence. , 2000, The American journal of clinical nutrition.

[33]  J. Cleeman,et al.  Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. , 1998, Preventive medicine.

[34]  H. Oda,et al.  Effects of excess dietary tyrosine on cholesterol, bile acid metabolism and mixed-function oxidase system in rats. , 1990, Journal of NutriLife.

[35]  Y. Deshaies,et al.  Relationship between dietary tyrosine and plasma cholesterol in the rat. , 1988, Canadian journal of physiology and pharmacology.

[36]  R. Kreisberg,et al.  Cholesterol metabolism and aging. , 1987, The American journal of medicine.